<DOC>
	<DOC>NCT01920542</DOC>
	<brief_summary>we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients</brief_summary>
	<brief_title>Dexmedetomidine on Pediatric Heart Operation</brief_title>
	<detailed_description>dexmedetomidine, a2-adrenoreceptor agonist has been used for sedation or hemodynamic stability for operative procedure. It had been already reported that dexmedetomidine reduce the impairment of renal functon after cardiac operation in adult. we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>16yr pediatric cardiac patients previous renal dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>